Estimations des analystes de Wall Street pour Solid Biosciences Inc. (SLDB): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-02 | $-0.37 | ||
| 2026-08-06 | $-0.38 | $-0.46 | +17.8% |
| 2026-05-12 | $-0.52 | $-0.40 | -30.0% |
| 2026-03-19 | $-0.50 | $-0.51 | +2.0% |
| 2025-11-03 | $-0.48 | $-0.42 | -14.3% |
| 2025-08-12 | $-0.42 | $-0.51 | +17.6% |
| 2025-05-15 | $-0.59 | $-0.53 | -11.3% |
| 2025-03-06 | $-0.89 | $-0.79 | -12.7% |
Ratios de valorisation
| Prix / Valeur comptable | 3.35 |
| EV / EBITDA | -4.09 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | 0 | $13.6M | $8.1M | 0 | 0 | 0 |
| Coût des Ventes | $56000 | 0 | $1.6M | $2.8M | $3.9M | 0 | 0 | $2.6M | $2.5M | $1.6M |
| Marge Brute | -$56000 | -$448000 | -$1.6M | -$2.8M | -$3.9M | $13.6M | $8.1M | -$2.6M | -$2.5M | -$1.6M |
| R&D | $20.1M | $39.9M | $58.0M | $94.7M | $64.9M | $58.7M | $78.4M | $76.6M | $96.4M | $140.3M |
| Frais Généraux | $5.5M | $15.0M | $17.7M | $24.6M | $21.6M | $27.1M | $28.9M | $27.8M | $33.3M | $38.9M |
| Charges Opérationnelles | $25.6M | $54.9M | $75.7M | $119.3M | $82.5M | $85.9M | $114.5M | $101.7M | $127.3M | $177.6M |
| Résultat Opérationnel | -$25.6M | -$54.9M | -$75.7M | -$119.3M | -$86.5M | -$72.3M | -$106.5M | -$104.3M | -$129.7M | -$179.2M |
| EBITDA | -$25.5M | -$54.4M | -$75.7M | -$116.5M | -$84.4M | -$69.2M | -$96.9M | -$93.4M | -$121.9M | -$172.7M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $340000 | 0 |
| Résultat Avant Impôts | -$23.8M | -$53.2M | -$74.8M | -$117.2M | -$88.3M | -$72.2M | -$86.0M | -$96.0M | -$124.7M | -$174.3M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$21.5M | -$52.1M | -$74.8M | -$117.2M | -$88.3M | -$72.2M | -$86.0M | -$96.0M | -$124.7M | -$174.3M |
| BPA | $-16.80 | $-24.26 | $-33.73 | $-43.05 | $-25.50 | $-10.14 | $-10.10 | $-4.83 | $-3.06 | $-1.99 |
| BPA Dilué | $-16.80 | $-24.26 | $-33.73 | $-43.05 | $-25.50 | $-10.14 | $-10.10 | $-4.83 | $-3.06 | $-1.99 |
| Actions en Circulation (Diluées) | $1.3M | $2.1M | $2.2M | $2.7M | $3.5M | $7.1M | $8.5M | $19.9M | $40.8M | $87.5M |
Prix
| Prix | $8.72 |
| Capitalisation | $858M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ANNX · AURA · AUTL · BNTC · DSGN · LBRX · NMRA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SLDB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions